Werewolf Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-32.6M | $-33.4M | $769.0K | $8.0M |
| FY2024 | $-56.2M | $-56.4M | $254.0K | $8.8M |
| FY2025 | $-60.3M | $-60.3M | $0 | $6.2M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-32.6M | $-33.4M | $769.0K | $8.0M |
| FY2024 | $-56.2M | $-56.4M | $254.0K | $8.8M |
| FY2025 | $-60.3M | $-60.3M | $0 | $6.2M |